TIDES 2006--IBC conference. Oligonucleotide and peptide technology and product development. 1-3 May 2006, Carlsbad, CA, USA.
Hartmann
Gunther
G
Department of Clinical Pharmacology, University of Bonn, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany. gunther.hartmann@ukb.uni-bonn.de
D000998:Antiviral Agents / Q000627:therapeutic use; D002140:California; D016503:Drug Delivery Systems; D015195:Drug Design; D006801:Humans; D019344:Lactic Acid; D008081:Liposomes; D008863:Microspheres; D009841:Oligonucleotides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000627:therapeutic use*; D010455:Peptides / Q000008:administration & dosage / Q000138:chemical synthesis / Q000627:therapeutic use*; D011092:Polyethylene Glycols; D011100:Polyglycolic Acid; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011108:Polymers; D034741:RNA, Small Interfering / Q000008:administration & dosage / Q000627:therapeutic use; D012164:Retinal Diseases / Q000188:drug therapy; D051217:Toll-Like Receptor 9 / Q000819:agonists; D016212:Transforming Growth Factor beta / Q000037:antagonists & inhibitors; D053781:Transforming Growth Factor beta2
D000998:Antiviral Agents; D008081:Liposomes; D009841:Oligonucleotides; D010455:Peptides; D011108:Polymers; D034741:RNA, Small Interfering; C509041:TGFB2 protein, human; C495371:TLR9 protein, human; D051217:Toll-Like Receptor 9; D016212:Transforming Growth Factor beta; D053781:Transforming Growth Factor beta2; D000077182:Polylactic Acid-Polyglycolic Acid Copolymer; D011100:Polyglycolic Acid; D019344:Lactic Acid; D011092:Polyethylene Glycols